Last $30.43 USD
Change Today -0.62 / -2.00%
Volume 1.1M
ACAD On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Uli Hacksell Ph.D.

Chief Executive Officer, President and Director, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 3 different industries.

See Board Relationships
64$4,818,869
As of Fiscal Year 2013

Background*

Dr. Uli Hacksell has been the Chief Executive Officer of ACADIA Pharmaceuticals Inc., since September 2000 and serves as its President. Dr. Hacksell served as the Chief Financial Officer and Chief Accounting Officer of ACADIA Pharmaceuticals Inc., from April 18, 2014 to July 2014. He served as an Executive Vice President of Drug Discovery from February 1999 to September 2000. From August 1991 to February 1999, Dr. Hacksell held various senior executive positions at Astra, ...

Read Full Background

Corporate Headquarters*

11085 Torreyana Road
San Diego, California 92121

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships*

Director
2000-Present
Chief Executive Officer, President and Director
2000-N/A
Former Chairman

Education*

PhD 1981
Uppsala Universitet
Master's Degree 1976
Uppsala Universitet

Other Affiliations*

Annual Compensation*

Salary$535,000
Bonus$400,000
Total Annual Compensation$935,000

Stock Options*

All Other Compensation$13,689
Exercised Options193,500
Exercised Options Value$2,726,308
Exercisable Options1,054,125
Unexercisable Options584,375
Total Value of Options$2,726,308
Total Number of Options1,832,000

Total Compensation*

Total Annual Cash Compensation$948,689
Total Short Term Compensation$935,000
Other Long Term Compensation$13,689
Total Calculated Compensation$4,818,869
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $30.43 USD -0.62

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$720.8K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.